Explore / Preprint
Preprint

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

Carhart-Harris RiD, Zeifman R, Pasquini L, Nandi B, Rohani-Shukla C, Suseelan S, Mediano PAMiD, Rosas FE, Timmermann C, Kettner HiD, McConnell PA

May 13, 20260 citationsDOI: 10.31234/osf.io/wzh7b_v1

Abstract

<p>First-line dictionary definitions of ‘plasticity’ describe it as the ability (of a thing) to be shaped or molded; we call this ‘plasticity proper’. In neuroscience, however, ‘neural plasticity’ or ‘neuroplasticity’ is defined as an induced change in brain function or structure. These two plasticities are not the same. Several (but not all) popular biomarkers of neuroplasticity index part of an evoked process, often linked to learning. Paradoxically, these processes often bias phenotypic canalization, the opposite of phenotypic plasticity. Recognizing this paradox puts into question the custom of using ‘plasticity’ as a shorthand for such neuroplastic phenomena, an overgeneralization that risks conflating assays of evoked brain changes with plasticity proper. We also question extrapolating from any biomarker of neuroplasticity (whether it be aligned with plasticity proper or not) to improved mental health. The relationship between the two is (naturally) context dependent. As a resolution, we propose a new construct ‘mediational and recalibrative plasticity’ (MR-P) and show how markers of it can describe and predict examples of phenotypic change, including psychological states and traits relevant to mental health. In contrast to many markers of neuroplasticity, MR-P is aligned with plasticity proper.</p>

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psychedelics

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.